[Ciprofloxacin in urinary infections: analysis of the Italian data pool].
Efficacy and safety of oral ciprofloxacin (500-1000 mg/die) were evaluated in 231 patients with bacteriologically documented infections of the urinary tract. The clinical resolution rate was 89.6% with eradication of the aetiological organism in 90.1% of cases. Superinfection, both bacterial or fungal, as well as side-effects were minimal. It is concluded that ciprofloxacin represents an effective and safe therapy in urinary tract infections.
Maggiolo
F
F
Bianchi
W
W
Ohnmeiss
H
H
D000284:Administration, Oral; D000328:Adult; D001424:Bacterial Infections / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002939:Ciprofloxacin
Ciprofloxacin nelle infezioni urinarie: analisi del data-pool italiano.